Sonnet BioTherapeutics Granted EU Patent for Innovative FHAB Technology
January 29, 2025 - 11:22
Sonnet BioTherapeutics has successfully obtained a patent from the European Patent Office (EPO) for its groundbreaking fully human albumin binding (FHAB) technology. This significant achievement underscores the company’s commitment to advancing therapeutic solutions that leverage the unique properties of human albumin.
The FHAB technology is designed to enhance the delivery and efficacy of various therapeutic agents, potentially transforming treatment options for patients with a range of medical conditions. By utilizing human albumin, Sonnet aims to improve the pharmacokinetics and bioavailability of drugs, thereby optimizing therapeutic outcomes.
This patent not only strengthens Sonnet's intellectual property portfolio but also positions the company as a leader in the biotherapeutics space. With the growing demand for innovative treatment modalities, the successful patent acquisition is expected to facilitate further research and development initiatives. The company is poised to explore new partnerships and collaborations to maximize the potential of its FHAB technology in the healthcare market.
MORE NEWS
June 7, 2025 - 20:23
Yageo Corp. to Retain Shibaura's AI Technology in Japan Following AcquisitionTaiwan`s Yageo Corp. has announced its intention to maintain the advanced artificial intelligence technology of Shibaura Electronics Co. in Japan, contingent upon a successful acquisition of the...
June 7, 2025 - 00:28
Pankaj K. Jha Awarded NSF Grant for Quantum Technology ResearchPankaj K. Jha, a prominent professor in the field of quantum technology, has recently been awarded a significant grant from the National Science Foundation (NSF) to further his research on...
June 6, 2025 - 01:39
Utilizing Smart Manufacturing Technology for the Next Generation of CNC MachinistsIn an era marked by rapid technological advancements, the manufacturing industry faces a pressing challenge: bridging the skills gap in the workforce. As smart manufacturing technologies continue...
June 5, 2025 - 09:18
FDA Greenlights Innovative AI Tool for Enhanced Breast Cancer DetectionA groundbreaking development in breast cancer detection has received approval from the FDA. This new AI technology, created by a pioneering tech company, marks the first instance of an FDA-approved...